Loading...
UTZ Brands Inc is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators are bearish, options sentiment is weak, financial performance is deteriorating, and analysts have lowered price targets. Additionally, there are no positive catalysts or proprietary trading signals to support a buy decision.
The MACD is negative and contracting, RSI is neutral at 39.347, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 9.478, with key support at 8.838 and resistance at 10.118. Overall, the technical trend is bearish.

NULL identified.
Analysts have lowered price targets, citing competitive concerns. Financial performance has significantly deteriorated, with negative net income and EPS. Recent news advises selling consumer staples like UTZ in favor of healthcare stocks.
In Q4 2025, revenue increased marginally by 0.34% YoY to $342.2M. However, net income dropped to -$2.5M (-208.04% YoY), EPS fell to -0.03 (-200% YoY), and gross margin declined to -3.97 (-111.34% YoY). Overall, the company's financials are weak.
Mizuho maintains an Outperform rating but lowered the price target to $14 from $16. UBS and Barclays lowered their price targets to $10 and $12, respectively, citing competitive concerns and range-bound trading. The consensus sentiment is mixed to negative.